-
NMPA Announcement on Issuing the List of Medical and Pharmaceutical Journals Approved to Advertise Prescription Drugs
2021-08-27
The Journal of Alzheimer's Disease and Related Diseases is approved to be included in the list of medical and pharmaceutical journals approved to advertise prescription drugs.
-
NMPA Announcement on Issuing the Catalogue of Reference Preparations of Generic Drugs (Forty-three Batch)
2021-07-23
On July 22, the Catalogue of Reference Preparations of Generic Drugs (Fortythree Batch) was issued, upon review and determination by the NMPA Experts Committee of Quality and Efficacy Consistency Evaluation of Generic Drugs.
-
NMPA Announcement on the Issues Related to the Implementation of the Measures for the Implementation of the Mechanism for Early Settlement of Drug Patent Disputes (interim)
2021-07-04
In order to complete the implementation of the Measures for the Implementation of the Mechanism for Early Settlement of Drug Patent Disputes (interim) (hereinafter referred to as the Measures), relevant issues are hereby announced on July 4 as follows.
-
Announcement of National Medical Products Administration and National Intellectual Property Administration on the Issuance of the Measures for the Implementation of the Mechanism for Early Settlement of Drug Patent Disputes (Interim)
2021-07-04
The National Medical Products Administration and the China National Intellectual Property Administration formulated the Measures for the Implementation of the Mechanism for Early Settlement of Drug Patent Disputes (interim).
-
NMPA Announcement on Issuing the Catalogue of Distribution of Class II Medical Devices Exempted from Filing
2021-06-30
In order to implement the Regulations on the Supervision and Administration of Medical Devices, the NMPA organized to formulate the Catalogue of Distribution of Class II Medical Devices Exempted from Filing, which was issued on June 28.
-
NMPA Announcement on Issuing the Catalogue of Reference Preparations of Generic Drugs (Forty-two Batch)
2021-06-25
On June 22, the Catalogue of Reference Preparations of Generic Drugs (Forty-two Batch) was issued, upon review and determination by the NMPA Experts Committee of Quality and Efficacy Consistency Evaluation of Generic Drugs.